VivoSim Labs
VIVS
122 hedge funds and large institutions have $71.6M invested in VivoSim Labs in 2016 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 8 closing their positions.
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
37% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 27
8% more capital invested
Capital invested by funds: $66.1M → $71.6M (+$5.48M)
6% more funds holding
Funds holding: 115 → 122 (+7)
0.01% more ownership
Funds ownership: 0.08% → 0.09% (+0.01%)
82% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $6.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.52M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$726K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$556K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$531K |
| 5 |
QI
Quotient Investors
New York
|
+$382K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$213K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$182K |
| 3 |
Morgan Stanley
New York
|
-$169K |
| 4 |
CI
Cowen Inc
New York
|
-$156K |
| 5 |
Bank of New York Mellon
New York
|
-$121K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
126
Bayesian Capital Management
Brooklyn,
New York
| – | -$42K | -47 | Closed |
|
127
ProShare Advisors
Bethesda,
Maryland
| – | -$39K | -44 | Closed |
|
|
VIA
128
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$32K | -36 | Closed |
|
|
TRCT
129
Tower Research Capital (TRC)
New York
| – | -$8K | -9 | Closed |
|
|
FNBT
130
FineMark National Bank & Trust
Fort Myers,
Florida
| – | -$7K | -8 | Closed |
|
VIVS Hedge Fund Activity: Q3 2016 in Review
122 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2016, worth a combined $71.6M — up 8.3% from $66.1M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new VIVS positions and 8 closed out — a net gain of 8 holders — while 37 added to existing stakes and 27 trimmed.
The largest buyer was UBS Group, adding an estimated $2.52M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $213K sold.
- 122 institutional investors held VivoSim Labs (VIVS) as of Q3 2016, up from 115 in Q2 2016.
- Funds reported $71.6M of VivoSim Labs stock for Q3 2016, up 8.3% quarter-over-quarter.
- 16 funds opened new VivoSim Labs positions in Q3 2016 and 8 closed out, a net change of +8 holders.
- The largest VivoSim Labs buyer in Q3 2016 was UBS Group, an estimated $2.52M added.
- The largest VivoSim Labs seller in Q3 2016 was Driehaus Capital Management, an estimated $213K sold.
Based on aggregated 13F filings for Q3 2016.